Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COV002: ChAdOx1 nCoV-19 Vaccine Efficacy Study
NCT04400838Phase 3Completed
- Sponsor
- University of Oxford
- Start
- May 2020
- Primary completion
- Feb 2025
- Modality
- Viral Vector Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of ChAdOx1 nCoV-19 in coronavirus disease 2019 (COVID-19), sponsored by University of Oxford. Started May 2020; status: completed.
02
Drugs
ChAdOx1 nCoV-19
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04400838.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04400838.